10 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Jan 2038. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Jan 2038
Next term end
6
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Aug 2040 · High confidence
Also notable
Ends Jan 2038 · High confidence
Also notable
Ends Apr 2040 · High confidence
Systems and Methods for Delivering Biomaterials
US 11,253,391
Cited by 13 later US patents, top 10% of utility patents granted in 2022 in our data. Protection runs to 2040.
Methods for Implanting and Reversing Stimuli-Responsive Implants
US 10,751,124
The most cited patent in this portfolio, cited by 22 later US patents, top 10% of utility patents granted in 2020 in our data. Protection runs to 2038.
Systems and Methods for Delivering Biomaterials
US 11,318,040
Cited by 11 later US patents, top 10% of utility patents granted in 2022 in our data. Protection runs to 2040.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Oct 9 to 16, 2027 · next Oct 9
Recent changes
- 2 of the patents on this record were granted since Aug 17, 2026
What they patent
The 5 largest of its 6 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Systems and Methods for Delivering Biomaterials (2019) | 3 in force | to Aug 2040 |
| Systems and Methods for Delivering Biomaterials (2019) | 2 in force | to Apr 2040 |
| Methods for Implanting and Reversing Stimuli-Responsive Implants | 2 in force | to Jul 2039 |
| Systems and Methods for Removing a Hydrogel Implant from a Body Lumen | 1 in force | to Oct 2043 |
| Biomaterial Compositions and Methods of Delivery | 1 in force | to Jun 2043 |
Patents held now
Soonest term end first.
Showing 1 to 10 of 10
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,751,124 | Methods for Implanting and Reversing Stimuli-Responsive Implants In force · High confidence | In force | High confidence | |
| US 12,383,421 | Contraceptive Devices In force · High confidence | In force | High confidence | |
| US 11,510,807 | Systems and Methods for Delivering Biomaterials In force · High confidence | In force | High confidence | |
| US 11,951,032 | Systems and Methods for Delivering Biomaterials In force · High confidence | In force | High confidence | |
| US 11,957,616 | Systems and Methods for Delivering Biomaterials In force · Medium confidence | In force | Medium confidence | |
| US D1,071,200 | Device for Delivering Injectable Material In force · High confidence | In force | High confidence | |
| US 11,318,040 | Systems and Methods for Delivering Biomaterials In force · High confidence | In force | High confidence | |
| US 11,253,391 | Systems and Methods for Delivering Biomaterials In force · High confidence | In force | High confidence | |
| US 12,708,554 | Biomaterial Compositions and Methods of Delivery In force · High confidence | In force | High confidence | |
| US 12,778,611 | Systems and Methods for Removing a Hydrogel Implant from a Body Lumen In force · High confidence | In force | High confidence |
Also on record, not counted in the 10: 5 applications pending · 5 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.